Susanna C Larsson1, Stephen Burgess2, Karl Michaëlsson3. 1. Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. 2. MRC Biostatistics Unit, University of Cambridge, United Kingdom3Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. 3. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Abstract
IMPORTANCE: Serum calcium has been associated with cardiovascular disease in observational studies and evidence from randomized clinical trials indicates that calcium supplementation, which raises serum calcium levels, may increase the risk of cardiovascular events, particularly myocardial infarction. OBJECTIVE: To evaluate the potential causal association between genetic variants related to elevated serum calcium levels and risk of coronary artery disease (CAD) and myocardial infarction using mendelian randomization. DESIGN, SETTING, AND PARTICIPANTS: The analyses were performed using summary statistics obtained for single-nucleotide polymorphisms (SNPs) identified from a genome-wide association meta-analysis of serum calcium levels (N = up to 61 079 individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium's 1000 genomes-based genome-wide association meta-analysis (N = up to 184 305 individuals) that included cases (individuals with CAD and myocardial infarction) and noncases, with baseline data collected from 1948 and populations derived from across the globe. The association of each SNP with CAD and myocardial infarction was weighted by its association with serum calcium, and estimates were combined using an inverse-variance weighted meta-analysis. EXPOSURES: Genetic risk score based on genetic variants related to elevated serum calcium levels. MAIN OUTCOMES AND MEASURES: Co-primary outcomes were the odds of CAD and myocardial infarction. RESULTS: Among the mendelian randomized analytic sample of 184 305 individuals (60 801 CAD cases [approximately 70% with myocardial infarction] and 123 504 noncases), the 6 SNPs related to serum calcium levels and without pleiotropic associations with potential confounders were estimated to explain about 0.8% of the variation in serum calcium levels. In the inverse-variance weighted meta-analysis (combining the estimates of the 6 SNPs), the odds ratios per 0.5-mg/dL increase (about 1 SD) in genetically predicted serum calcium levels were 1.25 (95% CI, 1.08-1.45; P = .003) for CAD and 1.24 (95% CI, 1.05-1.46; P = .009) for myocardial infarction. CONCLUSIONS AND RELEVANCE: A genetic predisposition to higher serum calcium levels was associated with increased risk of CAD and myocardial infarction. Whether the risk of CAD associated with lifelong genetic exposure to increased serum calcium levels can be translated to a risk associated with short-term to medium-term calcium supplementation is unknown.
IMPORTANCE: Serum calcium has been associated with cardiovascular disease in observational studies and evidence from randomized clinical trials indicates that calcium supplementation, which raises serum calcium levels, may increase the risk of cardiovascular events, particularly myocardial infarction. OBJECTIVE: To evaluate the potential causal association between genetic variants related to elevated serum calcium levels and risk of coronary artery disease (CAD) and myocardial infarction using mendelian randomization. DESIGN, SETTING, AND PARTICIPANTS: The analyses were performed using summary statistics obtained for single-nucleotide polymorphisms (SNPs) identified from a genome-wide association meta-analysis of serum calcium levels (N = up to 61 079 individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium's 1000 genomes-based genome-wide association meta-analysis (N = up to 184 305 individuals) that included cases (individuals with CAD and myocardial infarction) and noncases, with baseline data collected from 1948 and populations derived from across the globe. The association of each SNP with CAD and myocardial infarction was weighted by its association with serum calcium, and estimates were combined using an inverse-variance weighted meta-analysis. EXPOSURES: Genetic risk score based on genetic variants related to elevated serum calcium levels. MAIN OUTCOMES AND MEASURES: Co-primary outcomes were the odds of CAD and myocardial infarction. RESULTS: Among the mendelian randomized analytic sample of 184 305 individuals (60 801 CAD cases [approximately 70% with myocardial infarction] and 123 504 noncases), the 6 SNPs related to serum calcium levels and without pleiotropic associations with potential confounders were estimated to explain about 0.8% of the variation in serum calcium levels. In the inverse-variance weighted meta-analysis (combining the estimates of the 6 SNPs), the odds ratios per 0.5-mg/dL increase (about 1 SD) in genetically predicted serum calcium levels were 1.25 (95% CI, 1.08-1.45; P = .003) for CAD and 1.24 (95% CI, 1.05-1.46; P = .009) for myocardial infarction. CONCLUSIONS AND RELEVANCE: A genetic predisposition to higher serum calcium levels was associated with increased risk of CAD and myocardial infarction. Whether the risk of CAD associated with lifelong genetic exposure to increased serum calcium levels can be translated to a risk associated with short-term to medium-term calcium supplementation is unknown.
Authors: Qian Xiao; Rachel A Murphy; Denise K Houston; Tamara B Harris; Wong-Ho Chow; Yikyung Park Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Karen Kapur; Toby Johnson; Noam D Beckmann; Joban Sehmi; Toshiko Tanaka; Zoltán Kutalik; Unnur Styrkarsdottir; Weihua Zhang; Diana Marek; Daniel F Gudbjartsson; Yuri Milaneschi; Hilma Holm; Angelo Diiorio; Dawn Waterworth; Yun Li; Andrew B Singleton; Unnur S Bjornsdottir; Gunnar Sigurdsson; Dena G Hernandez; Ranil Desilva; Paul Elliott; Gudmundur I Eyjolfsson; Jack M Guralnik; James Scott; Unnur Thorsteinsdottir; Stefania Bandinelli; John Chambers; Kari Stefansson; Gérard Waeber; Luigi Ferrucci; Jaspal S Kooner; Vincent Mooser; Peter Vollenweider; Jacques S Beckmann; Murielle Bochud; Sven Bergmann Journal: PLoS Genet Date: 2010-07-22 Impact factor: 5.917
Authors: Sara Hägg; Tove Fall; Alexander Ploner; Reedik Mägi; Krista Fischer; Harmen H M Draisma; Mart Kals; Paul S de Vries; Abbas Dehghan; Sara M Willems; Antti-Pekka Sarin; Kati Kristiansson; Marja-Liisa Nuotio; Aki S Havulinna; Renée F A G de Bruijn; M Arfan Ikram; Maris Kuningas; Bruno H Stricker; Oscar H Franco; Beben Benyamin; Christian Gieger; Alistair S Hall; Ville Huikari; Antti Jula; Marjo-Riitta Järvelin; Marika Kaakinen; Jaakko Kaprio; Michael Kobl; Massimo Mangino; Christopher P Nelson; Aarno Palotie; Nilesh J Samani; Tim D Spector; David P Strachan; Martin D Tobin; John B Whitfield; André G Uitterlinden; Veikko Salomaa; Ann-Christine Syvänen; Kari Kuulasmaa; Patrik K Magnusson; Tõnu Esko; Albert Hofman; Eco J C de Geus; Lars Lind; Vilmantas Giedraitis; Markus Perola; Alun Evans; Jean Ferrières; Jarmo Virtamo; Frank Kee; David-Alexandre Tregouet; Dominique Arveiler; Philippe Amouyel; Francesco Gianfagna; Paolo Brambilla; Samuli Ripatti; Cornelia M van Duijn; Andres Metspalu; Inga Prokopenko; Mark I McCarthy; Nancy L Pedersen; Erik Ingelsson Journal: Int J Epidemiol Date: 2015-05-27 Impact factor: 7.196
Authors: Jon White; Daniel I Swerdlow; David Preiss; Zammy Fairhurst-Hunter; Brendan J Keating; Folkert W Asselbergs; Naveed Sattar; Steve E Humphries; Aroon D Hingorani; Michael V Holmes Journal: JAMA Cardiol Date: 2016-09-01 Impact factor: 14.676
Authors: Conall M O'Seaghdha; Hongsheng Wu; Qiong Yang; Karen Kapur; Idris Guessous; Annie Mercier Zuber; Anna Köttgen; Candice Stoudmann; Alexander Teumer; Zoltán Kutalik; Massimo Mangino; Abbas Dehghan; Weihua Zhang; Gudny Eiriksdottir; Guo Li; Toshiko Tanaka; Laura Portas; Lorna M Lopez; Caroline Hayward; Kurt Lohman; Koichi Matsuda; Sandosh Padmanabhan; Dmitri Firsov; Rossella Sorice; Sheila Ulivi; A Catharina Brockhaus; Marcus E Kleber; Anubha Mahajan; Florian D Ernst; Vilmundur Gudnason; Lenore J Launer; Aurelien Mace; Eric Boerwinckle; Dan E Arking; Chizu Tanikawa; Yusuke Nakamura; Morris J Brown; Jean-Michel Gaspoz; Jean-Marc Theler; David S Siscovick; Bruce M Psaty; Sven Bergmann; Peter Vollenweider; Veronique Vitart; Alan F Wright; Tatijana Zemunik; Mladen Boban; Ivana Kolcic; Pau Navarro; Edward M Brown; Karol Estrada; Jingzhong Ding; Tamara B Harris; Stefania Bandinelli; Dena Hernandez; Andrew B Singleton; Giorgia Girotto; Daniela Ruggiero; Adamo Pio d'Adamo; Antonietta Robino; Thomas Meitinger; Christa Meisinger; Gail Davies; John M Starr; John C Chambers; Bernhard O Boehm; Bernhard R Winkelmann; Jie Huang; Federico Murgia; Sarah H Wild; Harry Campbell; Andrew P Morris; Oscar H Franco; Albert Hofman; Andre G Uitterlinden; Fernando Rivadeneira; Uwe Völker; Anke Hannemann; Reiner Biffar; Wolfgang Hoffmann; So-Youn Shin; Pierre Lescuyer; Hughes Henry; Claudia Schurmann; Patricia B Munroe; Paolo Gasparini; Nicola Pirastu; Marina Ciullo; Christian Gieger; Winfried März; Lars Lind; Tim D Spector; Albert V Smith; Igor Rudan; James F Wilson; Ozren Polasek; Ian J Deary; Mario Pirastu; Luigi Ferrucci; Yongmei Liu; Bryan Kestenbaum; Jaspal S Kooner; Jacqueline C M Witteman; Matthias Nauck; W H Linda Kao; Henri Wallaschofski; Olivier Bonny; Caroline S Fox; Murielle Bochud Journal: PLoS Genet Date: 2013-09-19 Impact factor: 5.917
Authors: Golareh Agha; Michael M Mendelson; Cavin K Ward-Caviness; Roby Joehanes; TianXiao Huan; Rahul Gondalia; Elias Salfati; Jennifer A Brody; Giovanni Fiorito; Jan Bressler; Brian H Chen; Symen Ligthart; Simonetta Guarrera; Elena Colicino; Allan C Just; Simone Wahl; Christian Gieger; Amy R Vandiver; Toshiko Tanaka; Dena G Hernandez; Luke C Pilling; Andrew B Singleton; Carlotta Sacerdote; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Yun Li; Guosheng Zhang; James D Stewart; James S Floyd; Kerri L Wiggins; Jerome I Rotter; Michael Multhaup; Kelly Bakulski; Steven Horvath; Philip S Tsao; Devin M Absher; Pantel Vokonas; Joel Hirschhorn; M Daniele Fallin; Chunyu Liu; Stefania Bandinelli; Eric Boerwinkle; Abbas Dehghan; Joel D Schwartz; Bruce M Psaty; Andrew P Feinberg; Lifang Hou; Luigi Ferrucci; Nona Sotoodehnia; Giuseppe Matullo; Annette Peters; Myriam Fornage; Themistocles L Assimes; Eric A Whitsel; Daniel Levy; Andrea A Baccarelli Journal: Circulation Date: 2019-08-19 Impact factor: 29.690
Authors: William J Young; Helen R Warren; Dennis O Mook-Kanamori; Julia Ramírez; Stefan van Duijvenboden; Michele Orini; Andrew Tinker; Diana van Heemst; Pier D Lambiase; J Wouter Jukema; Patricia B Munroe; Raymond Noordam Journal: Circ Genom Precis Med Date: 2021-04-22